OPRX Earnings Prediction
The chart below shows how OPRX performed 10 days before and after its earnings report, based on data from the past quarters. Typically, OPRX sees a +5.18% change in stock price 10 days leading up to the earnings, and a +0.82% change 10 days following the report. On the earnings day itself, the stock moves by +6.43%. This data can give you a slight idea of what to expect for the next quarter's release.
OPRX Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
--
--
--
Gross Margin
--
--
--
Operating Margin
--
--
--
Net Margin
--
--
--
EPS
--
--
--
No Data Available
OPRX Earnings Analysis
OPTIMIZERx Corp Corporation (OPRX.O) Earnings Conference Call
Positive
Earnings Surprise: OptimizeRx Corporation beats earnings expectations with reported EPS of $0.3, exceeding expectations of $0.25.
Q4 Revenue Increase: Revenue for Q4 2024 reached $32.3 million, a 14% increase from $28.4 million in Q4 2023, driven by increased DAAP-related revenue streams.
Gross Margin Improvement: Gross margin improved from 62.9% in Q4 2023 to 68.2% in Q4 2024, attributed to a favorable solution and channel partner mix.
Operating Expenses Reduction: Operating expenses decreased by $10.4 million year-over-year due to lower M&A-related costs and cost-cutting initiatives, resulting in significant annual savings.
Net Loss Improvement: Net loss for Q4 2024 was only $0.1 million, a substantial improvement from a net loss of $4.1 million in Q4 2023.
Non-GAAP Net Income Increase: Non-GAAP net income for Q4 2024 was $5.5 million, or $0.30 per diluted share, compared to $4.6 million, or $0.26 per diluted share, in the same period last year.
Q4 EBITDA Increase: Adjusted EBITDA for Q4 2024 was $8.8 million, up from $5.8 million in Q4 2023, indicating strong operational performance.
Pharmaceutical Revenue Increase: Average revenue for the top 20 pharmaceutical manufacturers increased by 22% to $2.9 million, reflecting successful expansion of share of wallet with top manufacturers.
Net Revenue Retention Improvement: Net revenue retention rate improved to 121%, up from 105% in the previous year, showcasing strong customer loyalty and growth.
Revenue per FTE Increase: Revenue per FTE reached $701,000, surpassing the $586,000 reported in the previous year, indicating improved productivity.
Negative
Net Loss Improvement: The company reported a net loss of $0.1 million for Q4 2024, which, while an improvement from a net loss of $4.1 million in Q4 2023, still indicates ongoing financial challenges.
Liquidity Concerns Amid Revenue Growth: Despite a revenue increase of 14% year-over-year, the company’s cash and short-term investments decreased from $13.9 million in 2023 to $13.4 million in 2024, highlighting potential liquidity concerns.
Debt Impact on Operations: The current debt balance stands at $34.3 million, indicating a significant financial obligation that could impact future operational flexibility.
Subscription Model Transition Risks: The company is transitioning to a subscription-based model, which may involve risks and uncertainties during the conversion process, potentially affecting short-term revenue streams.
Adjusted EBITDA Analysis: While the company achieved a positive adjusted EBITDA of $8.8 million, this figure is still relatively modest compared to the overall revenue, suggesting that profitability remains a challenge.
CEO's Growth Phase Statement: The CEO's statement about being in a 'new phase' of growth and transformation may indicate previous struggles or a need for significant changes in strategy, which could imply instability in the company's direction.
OPRX FAQs
How does OPRX typically perform around its earnings report dates?
Is OPTIMIZERx Corp (OPRX) Q4 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
OPRX Earning Call Sentiment
OptimizeRx Corporation (NASDAQ:OPRX) Q4 2024 Earnings Call Transcript
OPRX.O
9.07%Positive
The company's financial performance shows significant improvements, including a 14% revenue increase, enhanced gross margins, and reduced net loss. The transition to a subscription model is expected to stabilize revenue streams. Despite management's vague responses in the Q&A, the overall sentiment is positive due to strong net revenue retention and client expansion. The absence of a shareholder return plan is a minor negative, but not enough to offset the positive financial metrics and growth strategy. Therefore, a positive stock price movement is anticipated over the next two weeks.
